|Articles|October 1, 2021
OTC Pearl of the Day: Vitamin B12
Author(s)Saro Arakelians, PharmD
Vitamin B12 injections or nasal spray may be prescribed to treat vitamin B-12 deficiency.
Advertisement
OTC Pearl of the Day: Vitamin B12
Indication: Vitamin B12 (cobalamin) plays an essential role in red blood cell formation, cell metabolism, nerve function, and the production of DNA, the molecules inside cells that carry genetic information.
Insight:
- Food sources of vitamin B12 include poultry, meat, fish, and dairy products.
- Vitamin B12 is also added to some foods, such as fortified breakfast cereals, and is available as an oral supplement.
- Vitamin B12 injections or nasal spray might be prescribed to treat vitamin B-12 deficiency.
- Older adults and people with digestive tract conditions that affect absorption of nutrients also are susceptible to vitamin B-12 deficiency.
- Adverse effects of B12 may include headache, nausea, vomiting, diarrhea, fatigue, weakness and tingling sensation in hands and feet.
- Interactions: B12 may interact with aminosalicylic acid, colchicine, metformin, proton pump inhibitors, vitamin C.
- Mechanism of action:Tissues absorb vitamin B12 by specific B12 binding proteins, transcobalamin I and II, allowing it to enter the cells. Most of the vitamin is stored in the liver. Vitamin B12 is essential for DNA synthesis and energy production, particularly in erythroid progenitor cells.
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Articles
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma
2
Updated IMWG Guidelines Spotlight MRD, Functional Imaging, and Light Chain Assays in Multiple Myeloma
3
IMS 2025: Future Directions for CAR T Therapy in Relapsed and Refractory Multiple Myeloma
4
Elranatamab Plus Daratumumab and Lenalidomide Yields Durable Responses, Manageable Safety
5